서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Communities & Collections

Journal Papers (저널논문_의학과)

  • in
  • Search for:
Browse
Issue DateTitle / Author(s) / CitationFileAltmetrics
2023-02
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG)
DOI
2023-02
Clinical Factors Affecting the Effectiveness of 1550-nm Erbium-Doped Fractional Photothermolysis Laser for Individual Atrophic Acne Scar Types

Lee, Soo Ran; Cho, Soyun

Dermatology and Therapy, Vol.13 No.2, pp.609-616

DOI
2023-02
Celebrating the 30th annual meeting of the Korean Society for investigative dermatology (KSID)

Cho, Soyun; Song, Won Ji; Choi, Eung Ho; Chung, Jin Ho

Annals of Dermatology, Vol.35 No.1, pp.1-5

DOI
2023-02
Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial
DOI
2023-02
Long-term outcomes in distinct phenogroups of patients with primary mitral regurgitation undergoing valve surgery
DOI
2023-02
Impact of discontinuing isolation in a private room for patients infected or colonized with vancomycin-resistant enterococci (VRE) on the incidence of healthcare-associated VRE bacteraemia in a hospital with a predominantly shared-room setting

Chang, E.; Im, D.; Lee, H.Y.; Lee, M.; Lee, C.M.; Kang, C.K.; Park, W.B.; Kim, N.J.; Choe, P.G.; Oh, M.

Journal of Hospital Infection, Vol.132, pp.1-7

DOI
2023-02
Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naïve individuals
DOI
2023-01
Extru-seq: a method for predicting genome-wide Cas9 off-target sites with advantages of both cell-based and in vitro approaches
view fileDOI
2023-01
Real-world evidence of switching P2Y12 receptor–inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry
view fileDOI
2023-01
Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations
DOI
2023-01
Application of Base Editor-Mediated Genome Editing in Mouse Retina

Wu, Jun; Cho, Chang Sik; Jo, Dong Hyun; Kim, Jeong Hun

Methods in molecular biology (Clifton, N.J.), Vol.2606, pp.179-188

DOI
2023-01
Comprehensive geriatric assessment and multidisciplinary team interventions for hospitalized older adults: A scoping review

Choi, Jung-Yeon; Rajaguru, Vasuki; Shin, Jaeyong; Kim, Kwang-Il

Archives of Gerontology and Geriatrics, Vol.104, p. 104831

DOI
2023-01
Distinct and overlapping features of nodal peripheral T-cell lymphomas exhibiting a follicular helper T-cell phenotype: a multicenter study emphasizing the clinicopathological significance of follicular helper T-cell marker expression
DOI
2023-01
Sex-related impact on clinical outcomes of patients treated with drug-eluting stents according to clinical presentation: Patient-level pooled analysis from the GRAND-DES registry
DOI
2023-01
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
DOI
2023-01
Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
DOI
2023-01
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis
DOI
2023-01
Risk of incident mental disorders in hypertrophic cardiomyopathy: a nationwide propensity-matched study
DOI
2023-01
The antitumor activity of a novel GCN2 inhibitor in head and neck squamous cell carcinoma cell lines
DOI
2023-01
Clinical impact of clonal hematopoiesis on severe COVID-19 patients without canonical risk factors
DOI
15 6 7 8 9 10 11210